These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass? Gosse P, Jullien V, Jarnier P, Lemetayer P, Clementy J. J Hum Hypertens; 1999 Aug; 13(8):505-9. PubMed ID: 10455470 [Abstract] [Full Text] [Related]
4. Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives? Cuspidi C, Meani S, Negri F, Giudici V, Valerio C, Sala C, Zanchetti A, Mancia G. J Hum Hypertens; 2009 Nov; 23(11):728-34. PubMed ID: 19322202 [Abstract] [Full Text] [Related]
5. Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD. Ruebner RL, Ng D, Mitsnefes M, Foster BJ, Meyers K, Warady B, Furth SL. Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1962-1968. PubMed ID: 27630183 [Abstract] [Full Text] [Related]
6. Relationship between 24-hour blood pressure pattern and left ventricular structure and function in hypertensive Nigerians. Nwafor CE, Adebiyi AA, Ogah OS, Falase AO. Ethn Dis; 2013 Nov 07; 23(4):474-9. PubMed ID: 24392611 [Abstract] [Full Text] [Related]
7. Achieving a Systolic Blood Pressure Below 130 mmHg Reduces the Incidence of Cardiovascular Events in Hypertensive Patients with Echocardiographic Left Ventricular Hypertrophy. Lembo M, Trimarco V, Izzo R, Manzi MV, Rozza F, Gallo P, Morisco C, Bardi L, Esposito G, Forzano I, Santulli G, Trimarco B. J Pharmacol Exp Ther; 2024 Jun 21; 390(1):4-10. PubMed ID: 38135511 [Abstract] [Full Text] [Related]
8. Impact of abdominal obesity and ambulatory blood pressure in the diagnosis of left ventricular hypertrophy in never treated hypertensives. Rodilla E, Costa JA, Martín J, González C, Pascual JM, Redon J. Med Clin (Barc); 2014 Mar 20; 142(6):235-42. PubMed ID: 24139053 [Abstract] [Full Text] [Related]
9. Clinical determinants of increased left ventricular mass on echocardiogram in medically treated Afro-Caribbean hypertensive patients. Martin TC, Bhaskar YG, Umesh KV. West Indian Med J; 2008 Sep 20; 57(4):337-41. PubMed ID: 19566012 [Abstract] [Full Text] [Related]
10. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7). Cuspidi C, Giudici V, Negri F, Meani S, Sala C, Zanchetti A, Mancia G. J Hypertens; 2009 Dec 20; 27(12):2465-71. PubMed ID: 19898252 [Abstract] [Full Text] [Related]
11. Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors. Jaleta GN, Gudina EK, Getinet W. BMC Res Notes; 2014 Jan 20; 7():45. PubMed ID: 24444396 [Abstract] [Full Text] [Related]
12. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors. Martinez-Vea A, Valero FA, Bardaji A, Gutierrez C, Broch M, Garcia C, Richart C, Oliver JA. Am J Nephrol; 2000 Jan 20; 20(3):193-200. PubMed ID: 10878400 [Abstract] [Full Text] [Related]
13. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, Lee ET, Devereux RB, Strong Heart Study Investigators. Am J Hypertens; 2005 Feb 20; 18(2 Pt 1):191-6. PubMed ID: 15752946 [Abstract] [Full Text] [Related]
14. Incidence of left ventricular hypertrophy in children with kidney disease: impact of method of indexation of left ventricular mass. Simpson JM, Savis A, Rawlins D, Qureshi S, Sinha MD. Eur J Echocardiogr; 2010 Apr 20; 11(3):271-7. PubMed ID: 20015849 [Abstract] [Full Text] [Related]
15. Blood pressure variability in controlled and uncontrolled blood pressure and its association with left ventricular hypertrophy and diastolic function. Wittke EI, Fuchs SC, Moreira LB, Foppa M, Fuchs FD, Gus M. J Hum Hypertens; 2016 Aug 20; 30(8):483-7. PubMed ID: 26467817 [Abstract] [Full Text] [Related]
16. Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes. Rodrigues JC, Amadu AM, Dastidar AG, Szantho GV, Lyen SM, Godsave C, Ratcliffe LE, Burchell AE, Hart EC, Hamilton MC, Nightingale AK, Paton JF, Manghat NE, Bucciarelli-Ducci C. Heart; 2016 Oct 15; 102(20):1671-9. PubMed ID: 27260191 [Abstract] [Full Text] [Related]
17. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study. Boman K, Gerdts E, Wachtell K, Dahlöf B, Nieminen MS, Olofsson M, Papademetriou V, Devereux RB. Eur J Cardiovasc Prev Rehabil; 2009 Apr 15; 16(2):242-8. PubMed ID: 19369828 [Abstract] [Full Text] [Related]
18. Prevalence of Doppler-Derived Left Ventricular Diastolic Dysfunction Among Newly Diagnosed Hypertensive Patients. Abubakar IG, Buba F, Oyati AI, Talle MA, Anjorin CO. Niger J Clin Pract; 2023 Nov 01; 26(11):1630-1636. PubMed ID: 38044766 [Abstract] [Full Text] [Related]
19. Prevalence and correlates of echocardiographic determined left ventricular hypertrophy in 2318 asymptomatic middle-aged men: the ECCIS project. Epidemiolgia e Clinica della Cardiopatia Ischemica Silente. Antoniucci D, Seccareccia F, Menotti A, Dovellini EV, Prati PL, Rovelli F, Fazzini PF. G Ital Cardiol; 1997 Apr 01; 27(4):363-9. PubMed ID: 9199953 [Abstract] [Full Text] [Related]
20. Features of left ventricular hypertrophy in patients with metabolic syndrome with or without comparable blood pressure: a meta-analysis. Li NY, Yu J, Zhang XW, Wang SX, Chang P, Ding Q, Ma RX, Chen QF, Zhao F, Bai F. Endocrine; 2013 Jun 01; 43(3):548-63. PubMed ID: 23371816 [Abstract] [Full Text] [Related] Page: [Next] [New Search]